Navigation Links
Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations
Date:12/15/2009

reast cancer specific survival (BCSS) benefit from chemotherapy in either the low (log-rank p=0.56) or intermediate (log-rank p=0.89) Recurrence Score categories; however, chemotherapy resulted in superior BCSS in the high Recurrence Score category (log-rank p=0.033).

Oncotype DX Leads to Fewer Recommendations of Chemotherapy for Women with Node-Positive Breast Cancer

  • A multi-institutional clinical survey presented on Friday, December 11 involving 160 physicians who currently use Oncotype DX in node-positive breast cancer patients found that treatment recommendations frequently changed based on Recurrence Score results, with an overall reduction in chemotherapy treatment recommendations. In the 138 patients with node-positive, hormone receptor-positive breast cancer where the physician had a specific treatment recommendation before obtaining the Oncotype DX Recurrence Score, recommended treatment changed from hormonal therapy plus chemotherapy to hormonal therapy alone in 46 patients (33%), and from hormonal therapy alone to hormonal therapy plus chemotherapy in 13 patients (9%) after obtaining the Recurrence Score.

Oncotype DX Can Be Successfully Performed on Breast Cancer Core Biopsy Samples, Suggesting Potential Role in Neoadjuvant Treatment Planning

  • On Sunday, December 13, researchers presented results from a study examining pathology review and quantitative RT-PCR analysis by Oncotype DX on more than 11,000 core biopsy samples processed at the Genomic Health laboratory between July 15, 2005 and May 31, 2009. Physicians use core needle biopsies to obtain breast cancer tumor tissue without surgery for the purposes of diagnosis. Surgery, adjuvant, and neoadjuvant treatment decisions are based on the analysis of core needle biopsy tissue. The overall Oncotype DX success rate in core biopsy samples was greater than 97 percent, demonstrating that R
    '/>"/>

SOURCE Genomic Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy
2. New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
3. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
4. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
5. Orion Genomics Enters Discovery Collaboration and License Agreement to Advance Personalized Diagnostics
6. Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute
7. Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Deploys Isilon IQ in Next Generation of Drug Development
8. CardioDx Completes Validation Study of First-Of-Its-Kind Genomic Test for Coronary Artery Disease
9. Curemark CEO Presents at Epigenomics Conference
10. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
11. Sirius Genomics Announces New Collaboration with Assistance Publique-Hopitaux de Paris
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  Strategic Health Services, Inc. ... solutions, today announced a strategic agreement with QualCare, Inc., a ... New Jersey regional marketplace.  This agreement will ... health and wellness solutions QualCare brings to its clients ... surrounding region. QualCare plans cover more ...
(Date:12/17/2014)... LOS ANGELES , Dec. 17, 2014 /PRNewswire/ ... that the US Patent and Trademark Office (USPTO) ... candidate ICT-107, a dendritic cell-based immunotherapeutic vaccine targeting ... glioblastoma. The claims of US Patent No. 8,871,211, ... treating neural cancer by administering a dendritic cell ...
(Date:12/15/2014)... 2014 Registreer nu via  http://bit.ly/ag8Sypm14de ... 20. Februar sind alle akkreditierten pharmazeutischen Patientenversorgungsakten-Firmen ... PARTNER PROGRAMM ™ 2015 in ... Diese Tagung soll dazu beitragen, der Aegate ... neue profitablen Unternehmensdienstleistungen, die für Apotheken und ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
...  Powered 4 Significance LLC, a Blue Ocean Pharma company, ... series yesterday on the topic, "What is the role ... series will include four debates over the course of ... other healthcare issues in future series. "We are extremely ...
... TEANECK, N.J., March 8, 2012  Herborium Group, Inc. (HBRM.PK) ... the Company, Internet sales  for first quarter of 2012 ... 2011. "During the Summer of 2011 we ... to build awareness of our brand and increase our ...
Cached Medicine Technology:Evidence-Based Medicine Debate Series Addresses Controversial Topics in the Diagnosis and Management of Alzheimer's Disease 2Evidence-Based Medicine Debate Series Addresses Controversial Topics in the Diagnosis and Management of Alzheimer's Disease 3Heborium Group Announces 23% Increase in 1st Quarter 2012 Revenue 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... SALT LAKE CITY, Dec. 17 Dynatronics Corporation (Nasdaq: ... board of directors and the execution of an agreement ... aid in strategic planning and improved corporate profitability. On ... with Vici Capital Partners for consulting services through its ...
... al. released this week and scheduled to be published in ... Medicine , concluded that while screening colonoscopy is associated with ... to deaths from cancer developing in the left side of ... a screening test and clarifies a possible weakness: detecting ...
... Researchers at Thomas Jefferson University have found that ... acoustic neuromas results in better hearing preservation and ... a higher dose of therapy. The study appeared ... Oncology*Biology*Physics . , "We previously had not determined ...
... between facilities also had higher mortality rates, study says ... those lacking insurance, make up the bulk of children ... , The study, published in a recent issue of ... that children who were transferred between hospitals died in ...
... SURGERY,S WORK COMES TO LIFE , , ... surgery. In fact, Maria Siemionow, MD, who performed this country,s ... reconstructive plastic surgeon. Facial transplantation plastic surgery offers great hope ... , "The nation,s first face transplant ...
... A new U.S. study has found that being circumcised ... African American men known to have been exposed to ... clinical trials in Africa, where interventional use of adult ... in heterosexual men. The findings of the new study, ...
Cached Medicine News:Health News:Dynatronics Announces Changes to Board and Launches Operational Improvement Process 2Health News:Annals colonoscopy study underscores importance of quality standards 2Health News:Lower-dose fractionated stereotactic radiotherapy results in better hearing preservation 2Health News:Newborn Hospital Deaths Highest for Those Without Insurance 2Health News:Plastic Surgery Experts Available to Comment on Face Transplant Surgery 2Health News:Circumcision reduces the risk of HIV infection in heterosexual US men 2
The ELISA test is used for detection and semi quantitation of igG antibodies to proteinase 3(PR3) in human sera, as an aid to the diagnosis is of Wegener's granulomatosis....
... MRSA is a differential medium designed ... of MRSA. Selective agents are incorporated ... most strains of S. epidermidis and ... substrate resulting in mauve colonies, thus ...
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
... is equipped with a 180 watt Xenon short arc ... energy transfer from the lamp to the light guide, ... is equivalent to higher watt bulbs. A new IR ... bulb reduces the amount of heat generated from the ...
Medicine Products: